AVARIJN Study

AVARIJN (Aortic VAlve RIJNmond) study about severe aortic stenosis: incidence, treatment and prognosis. A hospital-based multi-center prospective cohort study.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON29060

Enrollment

342

Registered

2008-10-17

Start date

2006-05-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Valve Stenosis, prognostic research.

Interventions

We establish patient characteristics, treatment strategy, functional status, quality of life, Doppler echocardiography, ECG and Nt-proBNP at baseline. After 6, 12 and 24 months, we repeat the echocard

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult patients with severe aortic valve stenosis, presented in the Erasmus medical Center or outpatient Cardiology clinic in the wider Rotterdam area. 2. Written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with previous aortic valve surgery or balloon dilatation. 2. Patients mentally disabled and/or suspect for senile dementia.

Design outcomes

Primary

Measure	Time frame
- Death	—

Secondary

Measure	Time frame
- Aortic valve replacement - Quality of life.	—

Contacts

Public ContactHelena J. Heuvelman

Erasmus Medical Center Department Cardiothoracic Surgery room Bd577 PO Box 2040

h.heuvelman@erasmusmc.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)